CD47 and PD-L1 both have a high profile in immuno-oncology as they can help tumours evade the innate and adaptive immune systems respectively. Targeting these responses in combination has exciting potential, so Absolute Antibody has developed an exclusive new research tool to help investigators explore it.
Mouse-anti-mouse bispecific antibody with silenced Fc effector function
Matched to host species for low immunogenicity
High purity and low endotoxin content for in vivo applications
Defined stoichiometry of binding regions
‘Mix-and-match’ from our other targets to build your own bispecific
Get in touch to arrange a quote!